In vivo and in vitro studies evaluating the chemopreventive effect of metformin on the aryl hydrocarbon receptor-mediated breast carcinogenesis

Metformin (MET) is a clinically used anti-hyperglycemic agent that shows activities against chemically-induced animal models of cancer. A study from our laboratory showed that MET protectes against 7, 12-dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis in vitro human non-cancerous epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhoshani, Ali, Alotaibi, Moureq, As Sobeai, Homood M., Alharbi, Naif, Alhazzani, Khalid, Al-Dhfyan, Abdullah, Alanazi, Fawaz E., Korashy, Hesham M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626299/
https://www.ncbi.nlm.nih.gov/pubmed/34867043
http://dx.doi.org/10.1016/j.sjbs.2021.08.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626299/
https://www.ncbi.nlm.nih.gov/pubmed/34867043
http://dx.doi.org/10.1016/j.sjbs.2021.08.051

Ejemplares similares